Combination of antigen-speciﬁc vaccination and targeted radionuclide therapy improves anti-tumor efﬁcacy in a murine prostate model

Provenge (sipuleucel-T) - Bausch Health

90Y-NM600 - Archeus Technologies

https://jitc.bmj.com//content/9/Suppl_2/A624

Hemanth Potluri ; Carolina Ferreira ; Joseph Grudzinski ; Christopher Massey ; Reinier Hernandez ; Jamey Weichert ; Douglas McNeel

Oct 1, 2021